How many institutional investors hold SPRY?

4 tracked institutional investors disclosed a position in SPRY (ARS PHARMACEUTICALS INC) in their most recent 13F filing.

Who is the largest institutional holder of SPRY?

Izzy Englander, Millennium Management, holds the largest disclosed position in SPRY, valued at $48M.

Where does this SPRY ownership data come from?

SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.

SPRY — ARS PHARMACEUTICALS INC

Name: ARS PHARMACEUTICALS INC (SPRY) — Institutional Ownership
Creator: InvestorLens
License: https://www.sec.gov/about/website-policies

Public company

For educational research only.InvestorLens analyzes public regulatory filings (SEC EDGAR, STOCK Act PTRs) that may be delayed by 45 days or more. Information shown is historical and is not financial, legal, or tax advice, nor a recommendation or solicitation to buy or sell any security. Always do your own research.

InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.

Sourced from SEC EDGAR public filings

Why are billionaires buying SPRY?

Built from public SEC filings and public economic data. Not a recommendation.

Confidence

Institutional Conviction

Net distribution · 1 buying vs 2 selling last quarter

Macro Tailwind

Macro conditions are mixed for this sector

Why? — Evidence & Confidence ▾

Of 3 tracked investors who changed their SPRY position last quarter, 1 bought and 2 sold (33% buy-side). Macro conditions are mixed for this sector (Macro Tailwind 57/100 in a Contraction regime).

Supporting evidence

+1 tracked investor added or increased positions last quarter (Paul Tudor Jones)
+4 tracked investors reported holding SPRY at their latest filing
+Macro Health is 57/100 in a Contraction regime — historically acceptable for this sectorsource

Contradicting evidence — always shown

−2 tracked investors reduced or exited last quarter (2 reduced, 0 sold out)
−13F data is disclosed up to 45 days after quarter end — positions may have changed since

Know the limits

· 13F disclosure lag (up to 45 days)
· Tracked investors are a sample, not the whole market
· Sector regime fit is a historical average, not a guarantee

Every InvestorLens score shows its evidence — including what argues against it. Model conviction-v1 · generated 9/6/2026.

About ARS PHARMACEUTICALS INC (SPRY)

ARS PHARMACEUTICALS INC (SPRY) appears in the most recent 13F filings of 4 tracked institutional investors. The largest disclosed position is held by Izzy Englander (Millennium Management), valued at $48M. Across recent filings, tracked investors recorded 6 new positions, 6 increased, 4 reduced, and 2 exited. All data sourced from SEC 13F filings.

Smart Money Consensus™

Based on recent institutional activity in SPRY

/100

Institutional Accumulation

Added / Increased12

Reduced4

Exited2

BearishBullish

Crowded Trade Score™

How many top investors track SPRY

/100

Emerging Interest

4investors

A small number of top investors own this.

UndiscoveredCrowded

151015+

SPRY Ownership Composition

How ARS PHARMACEUTICALS INC is held across tracked investor types, based on reported 13F positions.

Dominant Type

Multi-Strategy / Quant

75% of tracked value

Institutions

tracked investors

Total Reported

$33.1M

combined 13F value

Multi-Strategy / Quant74.7%
Activist24.2%
Macro1.1%

Multi-Strategy / Quant(2)

74.7%

Activist(1)

24.2%

Macro(1)

1.1%

Tracked investors currently reporting SPRY

1 tracked investor has since exited this position — listed separately below.

Investor	Firm	Shares	Market value	% of portfolio	As of
Izzy Englander	Millennium Management	2.5M	$20.2M	0.01%	Jun 30, 2026
Ken Griffin	Citadel Advisors	566.6K	$4.5M	0.00%	Jun 30, 2026
Daniel Loeb	Third Point LLC	1M	$8M	0.17%	Jun 30, 2026
Paul Tudor Jones	Tudor Investment Corp	45.9K	$367.6K	0.00%	Jun 30, 2026

Izzy EnglanderJun 30, 2026
Millennium Management
Shares
2.5M
Value
$20.2M
% Portfolio
0.01%
Ken GriffinJun 30, 2026
Citadel Advisors
Shares
566.6K
Value
$4.5M
% Portfolio
0.00%
Daniel LoebJun 30, 2026
Third Point LLC
Shares
1M
Value
$8M
% Portfolio
0.17%
Paul Tudor JonesJun 30, 2026
Tudor Investment Corp
Shares
45.9K
Value
$367.6K
% Portfolio
0.00%

Previously held SPRY

These investors reported SPRY in an earlier quarter but not in their most recent 13F. Figures below are their last reported position, not a current holding.

Investor	Firm	Last reported shares	Value then	Last held
Stanley Druckenmiller	Duquesne Family Office	536.9K	$7.8M	Sep 30, 2024

Recent activity

Investor	Action	Δ %	Current value	Filing date
Daniel Loeb	New	—	$6.5M	Feb 17, 2026
Daniel Loeb	Increased	79.78%	$8M	May 15, 2026
Daniel Loeb	Unchanged	0.00%	$8M	Aug 14, 2026
Izzy Englander	New	—	$7.1M	Nov 14, 2024
Izzy Englander	Increased	92.97%	$9.9M	Feb 14, 2025
Izzy Englander	Reduced	-14.08%	$10.2M	May 15, 2025
Izzy Englander	Increased	8.81%	$15.3M	Aug 14, 2025
Izzy Englander	New	—	$36.9M	Feb 17, 2026
Izzy Englander	Increased	88.83%	$48M	May 15, 2026
Izzy Englander	Reduced	-57.86%	$20.2M	Aug 14, 2026
Ken Griffin	Increased	158.48%	$6M	Nov 14, 2024
Ken Griffin	Reduced	-7.15%	$12.2M	May 15, 2025
Ken Griffin	Increased	142.50%	$41.2M	Aug 14, 2025
Ken Griffin	Sold	-100.00%	$0	Nov 14, 2025
Ken Griffin	Reduced	-69.21%	$4.5M	Aug 14, 2026
Paul Tudor Jones	New	—	$367.6K	Aug 14, 2026
Stanley Druckenmiller	New	—	$7.8M	Nov 14, 2024
Stanley Druckenmiller	Sold	-100.00%	$0	Feb 14, 2025
Ken Griffin	New	—	$1.4M	Aug 14, 2024

Daniel Loeb
New
$6.5MFeb 17, 2026
Daniel Loeb
Increased
$8M(79.78%)May 15, 2026
Daniel Loeb
Unchanged
$8M(0.00%)Aug 14, 2026
Izzy Englander
New
$7.1MNov 14, 2024
Izzy Englander
Increased
$9.9M(92.97%)Feb 14, 2025
Izzy Englander
Reduced
$10.2M(-14.08%)May 15, 2025
Izzy Englander
Increased
$15.3M(8.81%)Aug 14, 2025
Izzy Englander
New
$36.9MFeb 17, 2026
Izzy Englander
Increased
$48M(88.83%)May 15, 2026
Izzy Englander
Reduced
$20.2M(-57.86%)Aug 14, 2026
Ken Griffin
Increased
$6M(158.48%)Nov 14, 2024
Ken Griffin
Reduced
$12.2M(-7.15%)May 15, 2025
Ken Griffin
Increased
$41.2M(142.50%)Aug 14, 2025
Ken Griffin
Sold
$0(-100.00%)Nov 14, 2025
Ken Griffin
Reduced
$4.5M(-69.21%)Aug 14, 2026
Paul Tudor Jones
New
$367.6KAug 14, 2026
Stanley Druckenmiller
New
$7.8MNov 14, 2024
Stanley Druckenmiller
Sold
$0(-100.00%)Feb 14, 2025
Ken Griffin
New
$1.4MAug 14, 2024

Frequently asked questions

How many institutional investors hold SPRY?: 4 tracked institutional investors disclosed a position in SPRY (ARS PHARMACEUTICALS INC) in their most recent 13F filing.
Who is the largest institutional holder of SPRY?: Izzy Englander, Millennium Management, holds the largest disclosed position in SPRY, valued at $48M.
Did institutional ownership of SPRY increase or decrease?: Across recent 13F filings, tracked investors recorded 6 new positions, 6 increased, 4 reduced, and 2 fully exited SPRY.
Where does this SPRY ownership data come from?: SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.